Live briefing
Everything about Small-cell carcinoma
Type of malignant cancer
Small-cell carcinoma is a type of highly aggressive cancer that most commonly arises within the lungs, but can also occasionally arise in the cervix, prostate, bladder, and gastrointestinal tract. Compared to non-small cell carcinoma, small cell carcinoma is more aggressive, with a shorter doubling time, higher growth fraction, and earlier development of metastases. Wikipedia →
🧠Start here: a 6-step reading path
- Read the overview: Small-cell carcinomaA 5-minute orientation
- Skim a recent paper: Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trialInfluential work since 2022
- Pick up a classic book: Taschenbuch der mikroskopischen TechnikThe most-reprinted book on the subject
- Read the landmark paper: Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibCited 9,738 times
- Go sideways: Treatment of lung cancerA closely related topic
- Go sideways: Limited-stage small cell lung carcinomaA closely related topic
đź“– Definitions
No dictionary entry for this exact phrase.
🗂️ The subject at a glance
🏆 Landmark papers (most cited)
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
🆕 Influential since 2022
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
đź“š Books worth reading
Taschenbuch der mikroskopischen TechnikAlexander A. Böhm, Bohm · 1890- 📕Domestic MicrogenerationIain Staffell, Daniel J. L. Brett · 2015
Controversies in Lung CancerMovsas/Langer/g, Benjamin Movsas · 2001
Veterinary clinical epidemiologyRonald Dee Smith · 1991- 📕Marketing opportunities in the photovoltaic industryUnited States. Congress. House. Committee on Small Business. Subcommittee on Energy, Environment, and Safety Issues Affecting Small Business. · 1983
Systemic Treatment Of Nonsmall Cell Lung CancerGiuseppe Giaccone · 2012- 📕Small cell carcinomasJonathon G. Maldonado · 2009
- 📕Genetic approaches to understanding the functions of U2 and U6 snRNAs in mammalian pre-mRNA splicingJian Wu · 1993
Ranked by number of editions on Open Library, a rough measure of how lasting a book is.
đź”— Related topics
- Treatment of lung cancer Treatment of lung cancer refers to the use of medical therapies, such as surgery, radiation, chemotherapy, immunotherapy, percutaneous ablation, and palliative…
- Limited-stage small cell lung carcinoma Limited-stage small cell lung carcinoma (LS-SCLC) is a type of small-cell lung cancer (SCLC) that is confined to an area which is small enough to be encompassed…
- Atezolizumab Atezolizumab, sold under the brand name Tecentriq among others, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell…
- Non-small-cell lung cancer Non-small-cell lung cancer (NSCLC), or non-small-cell lung carcinoma, is a type of epithelial lung cancer other than small-cell lung cancer (SCLC). Non-small-ce…
- Adjuvant therapy Adjuvant therapy, also known as adjunct therapy, adjuvant care, or augmentation therapy, is a therapy that is given in addition to the primary or initial…
- Combined small-cell lung carcinoma Combined small cell lung carcinoma (or c-SCLC) is a form of multiphasic lung cancer that is diagnosed by a pathologist when a malignant tumor, arising…
- Transitional cell carcinoma Transitional cell carcinoma is a type of cancer that arises from the transitional epithelium, a tissue lining the inner surface of certain hollow organs…
- Targeted therapy of lung cancer Targeted therapy of lung cancer refers to using agents specifically designed to selectively target molecular pathways responsible for, or that substantially…